Identification of patients at increased risk for CKD offers the potential to prevent or delay ESRD and cardiovascular events through optimal antihypertensive regimens.
No takes yet. Share an insight, caveat, or question.
Risk stratification for CKD may inform hypertension care; leaves open prospective validation of optimal regimens.
K JAMERSON (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: